Large-scale testing (Phase 3)Study completedNCT02178215What this trial is testingEffect of Holly Mangrove Shower Gel in Atopic Dermatitis PatientsWho this might be right forAtopic Dermatitis Mahidol University 30
Not applicableAvailableNCT05466578What this trial is testingPre-approval Single-patient Expanded Access for Abrocitinib (PF-04965842)Who this might be right forSevere Uncontrolled Atopic Dermatitis Pfizer
Large-scale testing (Phase 3)Active Not RecruitingNCT05492578What this trial is testingLong-Term Safety and Efficacy Evaluation of Amlitelimab in Participants of Previous Amlitelimab Moderate to Severe Atopic Dermatitis Clinical TrialsWho this might be right forDermatitis Atopic Sanofi 1,856
Not applicableStudy completedNCT05904509What this trial is testingInsulin Resistance in Atopic Dermatitis PatientsWho this might be right forAtopic Dermatitis Bezmialem Vakif University 32
Early research (Phase 1)Not Yet RecruitingNCT07549984What this trial is testingIBI3033 in Moderate-to-Severe Atopic DermatitisWho this might be right forAtopic Dermatitis Innovent Biologics (Suzhou) Co. Ltd. 16
Not applicableStudy completedNCT02003599What this trial is testingLaser InGaAlP (660Nm) to Prevent Radiodermatitis in Breast Cancer Patients Submitted to Radiation TherapyWho this might be right forRadiotherapy; Adverse Effect, Dermatitis or EczemaBreast Neoplasms Universidade do Vale do Sapucai 52
Large-scale testing (Phase 3)Active Not RecruitingNCT03989206What this trial is testingLong-term Safety and Efficacy of Nemolizumab With Moderate-to-severe Atopic DermatitisWho this might be right forModerate-to-Severe Atopic Dermatitis Galderma R&D 1,700
Large-scale testing (Phase 3)Study completedNCT00351052What this trial is testingSteroid-Sparing Effect With Pimecrolimus in Pediatric Patients With Atopic DermatitisWho this might be right forAtopic Dermatitis Novartis 184
Large-scale testing (Phase 3)Study completedNCT03733301What this trial is testingBaricitinib (LY3009104) in Combination With Topical Corticosteroids in Adults With Moderate to Severe Atopic DermatitisWho this might be right forAtopic Dermatitis Eli Lilly and Company 329
Testing effectiveness (Phase 2)Ended earlyNCT03568071What this trial is testingAssess Efficacy, Safety, Tolerability and Pharmacokinetics (PK)/Pharmacodynamics (PD) of MOR106 in Subjects With Moderate to Severe Atopic DermatitisWho this might be right forAtopic Dermatitis Lakefront Biotherapeutics NV 207
Testing effectiveness (Phase 2)Study completedNCT06024499What this trial is testingPhase 2 Trial of HY209gel in Atopic Dermatitis PatientsWho this might be right forAtopic DermatitisAtopic Dermatitis EczemaAtopic Dermatitis of Scalp Shaperon 210
Early research (Phase 1)Study completedNCT02466152What this trial is testingPharmacokinetic Study of Topical GSK2894512 CreamWho this might be right forDermatitis, Atopic GlaxoSmithKline 11
Not applicableUnknownNCT04606615What this trial is testingSkin Barrier Abnormalities and Oxidative Stress ResponseWho this might be right forAtopic DermatitisFood Allergy National Jewish Health 160
Testing effectiveness (Phase 2)Ended earlyNCT00996008What this trial is testingCT 327 in the Treatment of Atopic DermatitisWho this might be right forMild to Moderate Atopic Dermatitis Creabilis SA 15
Not applicableStudy completedNCT03632174What this trial is testingEvaluation and Comparison of 2 Cosmetic Investigational Products in Adults With Atopic DermatitisWho this might be right forAtopic Dermatitis BioGaia AB 36
Not applicableLooking for participantsNCT03361215What this trial is testingDisease Trajectories and Anti-cytokine Response Signatures in Atopic Dermatitis and PsoriasisWho this might be right forAtopic DermatitisPsoriasisHealthy University Hospital Schleswig-Holstein 1,000
Testing effectiveness (Phase 2)Study completedNCT00980135What this trial is testingSinecort Pilot Efficacy StudyWho this might be right forAtopic Dermatitis Bayer 40
Testing effectiveness (Phase 2)Study completedNCT00354510What this trial is testingTopical GW842470X In Adults Patients With Moderate Atopic DermatitisWho this might be right forAtopic DermatitisDermatitis, Atopic GlaxoSmithKline 190
Early research (Phase 1)Ended earlyNCT06469385What this trial is testingTopical ENS-002 for Atopic Dermatitis in AdultsWho this might be right forAtopic DermatitisAtopic Dermatitis Eczema Concerto Biosciences 9
Post-approval studies (Phase 4)Study completedNCT00509990What this trial is testingOpen Label Study of Long Term Treatment of Pediatric Treatment of Atopic Dermatitis With Pimecrolimus Cream 1% Within a Usual Clinical SettingWho this might be right forAtopic Dermatitis Novartis Pharmaceuticals 200